Vnitr Lek 2022, 68(7):E23-E27 | DOI: 10.36290/vnl.2022.102

Primary cardiac synovial sarcoma mimicking SARS-CoV-2 associated pericarditis

Eva Cinková, Ondrej Ondič, Alexander Malán
II. interní klinika Fakultní nemocnice Plzeň
Šiklův ústav patologie lékařské fakulty UK v Plzni a Fakultní nemocnice Plzeň
Klinika zobrazovacích metod Fakultní nemocnice Plzeň

Primary cardiac synovial sarcoma is an extremely rare tumor with a higher incidence in young men. The mean age of occurrence is 32 years. Synovial sarcomas are tumors with high aggressiveness, proliferate rapidly and metastasize to regional and distant lymph nodes or surrounding organs. The typical location of synovial sarcoma of the heart is the atrial and ventricular septum. Its size, the degree of infiltration of the surrounding tissues and the presence of metastases influence clinical symptoms, which are very non-specific. The low specificity of the symptoms complicates the clinical diagnosis and in most cases the tumor is detected during its progression or incidentally. The final diagnosis is based on histological examination. The primary and only method of treatment is a surgical solution with an effort to completely resect the tumor, followed by aggressive palliative chemotherapy. In the following paper, we present a case report of a 32-year-old man who was diagnosed with synovial cardiac sarcoma only on the basis of exacerbation of non-specific subjective complaints due to the complication in the form of of aneurysmal bleeding of the tumor mass.

Keywords: chemotherapy, heart tumors, sarcoma, SARS‑CoV-2.

Accepted: October 26, 2022; Published: October 31, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cinková E, Ondič O, Malán A. Primary cardiac synovial sarcoma mimicking SARS-CoV-2 associated pericarditis. Vnitr Lek. 2022;68(7):E23-27. doi: 10.36290/vnl.2022.102.
Download citation

References

  1. World Health Organization Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours, 5th ed, International Agency for Research on Cancer, 2020. Vol 3.
  2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7. Go to original source... Go to PubMed...
  3. Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64:83. Go to original source... Go to PubMed...
  4. Miller KD, Fidler‑Benaoudia M, Keegan TH et al. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020;70:443. Go to original source... Go to PubMed...
  5. Burke A, Virmani R. Primary cardiac sarcomas. Atlas of tumor pa_thology. Tumors of the heart and great vessels. 1990;16:127-70.
  6. Patel J, Sheppard MN. Pathological study of primary cardiac and pericardial tumours in a specialist UK centre: surgical and autop_sy series. Cardiovasc Pathol. 2010;19:343-52. Go to original source... Go to PubMed...
  7. Hamidi M, Moody JS, Weigel TL, Kozak KR. Primary cardiac sarco_ma. Ann Thorac Surg. 2010;90:176-81. Go to original source... Go to PubMed...
  8. Piazza N, Chughtai T, Toledano K et al. Primary cardiac tumors: Eighteen years of surgical experience on 21 patients. Can J Cardiol. 2004;20:1443-1448.
  9. Birdsall S, Osin P, Lu YJ et al. Synovial sarcoma specific translocation associated with both epithelial and spindle cell components. Int J Cancer. 1999;82:605- 608. Go to original source...
  10. Debourdeau P, Gligorov J, Teixeira L et al. Maligant cardiac tumors. Bull Cancer. 2004;91:136-146.
  11. Sheu CC, Lin SF, Chiu CC et al. Left atrial sarcoma mimicking obstructive pulmonary disease. J Clin Oncol. 2007;25:1277. Go to original source... Go to PubMed...
  12. Lee VH, Connolly HM, Brown RD Jr. Central nervous system manifestations of cardiac myxoma. Arch Neurol. 2007;64:1115. Go to original source... Go to PubMed...
  13. Grande AM, Ragni T, Viganò M. Primary cardiac tumors. A clinical experience of 12 years. Tex Heart Inst J. 1993;20:223-30.
  14. Gowdamarajan A, Michler RE. Therapy for primary cardiac tumors: is there a role for heart transplantation? Curr Opin Cardiol. 2000;15:121-5. Go to original source... Go to PubMed...
  15. Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Car_diac tumors: diagnosis and management. Lancet Oncol. 2005;6:219-28. Go to original source... Go to PubMed...
  16. Prosnitz RG, Chen YH, Marks LB. Cardiac toxicity following thoracic radiation. Semin Oncol. 2005;32:71-80. Go to original source... Go to PubMed...
  17. Llombart‑Cussac A, Pivot X, Contesso G, Rhor‑Alvarado A, Delord JP, Spielmann M, Türsz T, Le Cesne A. Adjuvant chemotherapy for primary cardiac sarcoma: the IGR experience. Br J Cancer. 1998;78:1624-8. Go to original source... Go to PubMed...
  18. Simpson L, Kumar SK, Okuno SH, Schaff HV, Porrata LF, Buckner JC, Moynihan TJ. Malignant primary cardiac tumors: review of a single institution experience. Cancer. 2008;112:2440-6. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.